Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Filings indexed 1,754 across all filing types
Latest filing 2026-05-28 Proxy Solicitation & In…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Newspaper Advertisement - Intimation of 53rd Annual General Meeting of the Company through VC/OAVM
Proxy Solicitation & Information Statement Classification · 80% confidence The document is a formal announcement and notice of the company’s 53rd Annual General Meeting (AGM), including e-voting instructions and details of the meeting resolutions. It is not the Annual Report itself, nor an earnings release, management change notice, or other category. It constitutes proxy solicitation materials (i.e., information sent to shareholders to inform them of the meeting and request their votes). Under the taxonomy, this corresponds to Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 68% confidence The document is the formal Notice of the 53rd Annual General Meeting published in the newspaper and sent to the stock exchanges and shareholders, including details on the AGM, e‐voting procedures, record date, and availability of the Integrated Annual Report. This constitutes materials sent to members to provide information about the meeting and to solicit votes (remote e‐voting and e‐voting during the AGM). Under our taxonomy, these are proxy solicitation/information statement materials rather than the meeting presentation itself or a simple report‐publication announcement.
2026-05-28 English
Earning Call Transcript
Report Publication Announcement Classification · 85% confidence The document is a brief notice to stock exchanges under SEBI LODR Reg. 30 that the transcript of the analysts/investor conference call on audited results has been placed on the company’s website. It does not contain the transcript itself or substantive financial data, but merely announces the publication of that report. This fits the definition of a Report Publication Announcement (RPA).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 92% confidence The document is a stock exchange filing notifying that the transcript of a conference call has been placed on the company’s website. It does not contain the actual transcript, but merely announces its publication in compliance with SEBI Listing Regulations. This matches the definition of a Report Publication Announcement (RPA), rather than a Call Transcript (CT) or another filing type.
2026-05-27 English
Annual Secretarial Compliance Report for 2025-26
Regulatory Filings Classification · 91% confidence The document is titled “Annual Secretarial Compliance Report for the year ended 31-Mar-26” and is issued under Regulation 24A of SEBI (LODR) Regulations. It is a compliance certificate by a practicing company secretary covering statutory and listing compliances, not a financial statement (10-K/IR) or an audit of financials, nor an announcement of a report’s publication. It constitutes a general regulatory filing/certificate under SEBI rules. Thus, it falls into the “Regulatory Filings” (RNS) category.
2026-05-23 English
Audio Recording of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2026
Regulatory Filings Classification · 90% confidence The document is a stock exchange disclosure letter informing that the audio recording of the analysts/investors conference call on audited financial results has been posted on the company website. It contains no financial data itself and is simply a regulatory announcement of where to access the call recording. It does not include the transcript or actual earnings figures, so it does not qualify as a Call Transcript (CT) or Earnings Release (ER). This is a general regulatory announcement and thus falls under the fallback category Regulatory Filings (RNS).
2026-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.